Both in Diagnostics
Immucell vs QuidelOrtho
Over the past year ICCC returned +70.0% and QDEL returned −49.4%; their daily moves had a correlation of 0.07.
ICCC +70.0% QDEL −49.4%Growth of $1, one year, split-adjusted
| Metric | ICCC | QDEL |
|---|---|---|
| Price | $10.56 | $14.03 |
| Market cap | $95.9M | $962.1M |
| Today | +2.92% | +5.89% |
| 1 month | +8.3% | +30.3% |
| 6 months | +21.1% | +13.0% |
| Year to date | +71.7% | −50.9% |
| 1 year | +73.4% | −47.7% |
| Revenue growth (YoY) | +11.5% | +2.8% |
| Gross margin | 33.9% | 43.3% |
| Net margin | 25.5% | −14.7% |
| P/E (TTM) | 121.8× | — |
| Price / sales | 3.1× | 0.4× |
| Net cash | $557.3K | -$2.77B |
| Dividend yield | — | — |
| Volatility (60d) | 37.9% | 69.6% |
| Short % of float | 0.3% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).